Use of a surfactant for the preparation of a formulation for the treatment of adipose diseases
OwnerPeter Boderke, Bernhard Hauptmeier +3inventors
InventorsPeter Boderke, Bernhard Hauptmeier, Edgar Mentrup, Holger Kohler, Rainer Pooth
Life of this patent
Estimating the term…
Abstract
Use of a mixture comprising at least one non-aromatic surfactant having a plurality of ether and/or ester groups and at least one carrier agent for the preparation of a formulation for the treatment of adipose tissue disease and/or condition with improved bioavailability and lipolysis behaviour.
Claims22
1-22. (canceled)
A method for the treatment of an adipose tissue disease and/or condition comprising administering to a human or animal subject, an effective amount of a preparation comprising at least one non-aromatic surfactant having a plurality of ether and/or ester groups and at least one carrier agent.
A method for the treatment of an adipose tissue disease and/or condition comprising subcutaneously administering to a human or animal subject, an effective amount of an injection product comprising of at least one non-aromatic surfactant having a plurality of ether and/or ester groups and at least one carrier agent for the subcutaneous treatment of adipose tissue disease and/or condition.
A preparation comprising at least one non-aromatic surfactant having a plurality of ether and/or ester groups and at least one carrier agent which is administered to a human or animal subject in an amount effective for the treatment of an adipose tissue disease and/or condition.
Dependencies are inferred from the claim text.